Søren Johan Brun
2022 NEW YEARS GREETING (DK&ENG)
Copenhagen, January 1, 2022 To download the 2022 New Years Greeting in English, press here. Gemstone Capital New Year 2022 To download the 2022 New Years Greeting in Danish, press here. Gemstone Capital Nytår 2022
Gemstone Capital promotes Kristoffer Lippert to Associate Director and opens up for new career opportunities.
Copenhagen, January 1 2021 We are happy to announce that as of January 1st, 2022, Kristoffer is promoted to Associate Director at Gemstone Capital. Kristoffer joined the Gemstone team in the fall of 2020 as Project Manager. From day one, he stepped into his role with enthusiasm and a strong can-do attitude. He has been…
2021: Pre-IPO funding in numbers
December 2021: 4.6mDKK Pre-IPO funding for life-science company DK life-science company [name undisclosed] with unique platform technology closes a pre-IPO round, as a last step prior to an anticipated IPO in 2022. Gemstone acts as the Company’s financial advisor, and facilitated the process and transaction. June 2021: 10.2mDKK pre-IPO convertible loan for Brain+ Brain+ closes…
Freetrailer spotted by Nordnet as best share in Denmark in 2021 with 354% return
Copenhagen, December 2021 “Best Danish share, if we look at all shares in Denmark (and not just C25) is Freetrailer with a return of as much as 354% (!)” Freetrailer was Gemstone Capital’s IPO #5 (2018) Read more about the win here (in Danish).
Brain+ lands partnership with Roche
Copenhagen, December 2021 Brain+ lands partnership with Roche for entry in Germany 2 years ahead of plan. “Brain+ has signed a partnership agreement with RoX Health (https://roxhealth.com/), a subsidiary of the global pharma company Roche in Germany, to bring its first dementia products to the German market.” Read more about the partnership HERE. Brain+…
Expres2ion Biotechnologies announces positive results for its breast cancer vaccine
Copenhagen, December 2021 “ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that its capsid virus-like particle (cVLP) breast cancer vaccine candidate ES2B-C001 demonstrated strong tumor-growth inhibiting effect in a mice model, thus reaching an important pre-clinical milestone ahead of schedule.” Read more about the exciting news HERE. Expres2ion was Gemstone Capital’s first IPO…
Expres2ion Biotechnologies announces positive results for its covid-19 vaccine
Copenhagen, December 2021 “ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that the ABNCoV2 vaccine demonstrated a strong boosting effect in the clinical Phase II trial conducted by Bavarian Nordic. ” Read more about the exciting news HERE. Expres2ion was Gemstone Capital’s first IPO (2016)
Investorugen 2021, Danish Shareholders Association (in Danish)
Copenhagen, 16 November 2021 Managing Partner Søren Jonas Bruun in the studio [03:35:50] on the status on the First North market in Copenhagen and announcing Gemstone research comparing the Danish and Swedish markets.
Realfiction shares optimistic update on its ground-breaking ECHO technology
Copenhagen, December 2021 “We are thrilled to be working together with world leading research organizations like Fraunhofer FEP and imec. Their expertise in this area is highly renown, and the fact that they are committed and enthusiastic about our project makes me very confident that we will achieve our goal,” says Clas Dyrholm, CEO of…
Brain+ IPO 169% subscribed by 1,288 investors
Copenhagen, December 2021 The total subscription in the IPO was DKK 25.4 million from a total of 1,288 subscribers, translating into a subscription percentage of 169% counting all shares offered in the offering. Read more HERE. Brain+ was Gemstone Capital’s IPO company #12 (2021)